Association between HER2 germline mutation A270S and prognosis in patients with primary breast cancer.
- Published in:
- Cancer Biomarkers, 2018, v. 23, n. 2, p. 165, doi. 10.3233/CBM-170466
- By:
- Publication type:
- Article
Works by Fan, Zhaoqing
Results: 56
1
2
A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women.
- Published in:
- Human Mutation, 2011, v. 32, n. 9, p. 1000, doi. 10.1002/humu.21538
- By:
- Publication type:
- Article
3
Observation Effectiveness of Dose-Dense Neoadjuvant Anthracycline Sequential Weekly Paclitaxel for Triple-Negative Breast Cancer Patients.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 4, p. 423, doi. 10.1016/j.clbc.2023.02.009
- By:
- Publication type:
- Article
4
HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer.
- Published in:
- Oncology Letters, 2017, v. 13, n. 5, p. 3793, doi. 10.3892/ol.2017.5866
- By:
- Publication type:
- Article
5
A Non-Inferior Randomized Trial of Neoadjuvant Endocrine Therapy Compared to Neoadjuvant Chemotherapy in Premenopausal Patients With Hormone-Responsive and HER2-Negative Lymph Node-Negative Breast Cancer.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2025, p. 1, doi. 10.1177/10732748251339958
- By:
- Publication type:
- Article
6
Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1203-3
- By:
- Publication type:
- Article
7
Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 5, p. 1235, doi. 10.1007/s00432-019-02873-8
- By:
- Publication type:
- Article
8
Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 4, p. e216259, doi. 10.1001/jamanetworkopen.2021.6259
- By:
- Publication type:
- Article
9
The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.
- Published in:
- Acta Oncologica, 2006, v. 45, n. 5, p. 597, doi. 10.1080/02841860600660803
- By:
- Publication type:
- Article
10
Diagnostic accuracy of sentinel lymph node biopsy and wire localized clipped node biopsy after neoadjuvant chemotherapy in node-positive breast cancer.
- Published in:
- Surgery Today, 2025, v. 55, n. 2, p. 172, doi. 10.1007/s00595-024-02981-0
- By:
- Publication type:
- Article
11
Is Surgical Excision Necessary in Breast Papillomas 10 mm or Smaller at Core Biopsy.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 1, p. 29, doi. 10.1159/000481097
- By:
- Publication type:
- Article
12
Neoadjuvant chemotherapy using epirubicin, cyclophosphamide and fluorouracil; neutropenia and elevation of transaminase, and their management.
- Published in:
- Chinese Journal of Oncology, 2015, v. 37, n. 3, p. 204, doi. 10.3760/cma.j.issn.0253-3766.2015.03.010
- By:
- Publication type:
- Article
13
Effect of Local Versus General Anesthesia in Breast-Conserving Surgery on Cancer Recurrence and Cost.
- Published in:
- 2022
- By:
- Publication type:
- journal article
14
Intensive treatment of triple negative breast cancer with residual positive axillary lymph node after neoadjuvant chemotherapy.
- Published in:
- BMC Women's Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12905-024-03441-0
- By:
- Publication type:
- Article
15
Germline mutation in DNA‐repair genes is associated with poor survival in BRCA1/2‐negative breast cancer patients.
- Published in:
- Cancer Science, 2019, v. 110, n. 10, p. 3368, doi. 10.1111/cas.14175
- By:
- Publication type:
- Article
16
Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA‐negative breast cancers.
- Published in:
- Cancer Science, 2018, v. 109, n. 1, p. 166, doi. 10.1111/cas.13426
- By:
- Publication type:
- Article
17
HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers.
- Published in:
- Cancer Science, 2017, v. 108, n. 4, p. 671, doi. 10.1111/cas.13182
- By:
- Publication type:
- Article
18
Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
19
Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00553-y
- By:
- Publication type:
- Article
20
Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer.
- Published in:
- Frontiers of Medicine, 2013, v. 7, n. 1, p. 138, doi. 10.1007/s11684-013-0247-5
- By:
- Publication type:
- Article
21
RAD50 germline mutations are associated with poor survival in BRCA1/2–negative breast cancer patients.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 8, p. 1935, doi. 10.1002/ijc.31579
- By:
- Publication type:
- Article
22
TP53 mutations are associated with higher rates of pathologic complete response to anthracycline/cyclophosphamide-based neoadjuvant chemotherapy in operable primary breast cancer.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 2, p. 489, doi. 10.1002/ijc.29715
- By:
- Publication type:
- Article
23
Effect of p53 codon 72 genotype on breast cancer survival depends on p53 gene status.
- Published in:
- International Journal of Cancer, 2008, v. 122, n. 12, p. 2761, doi. 10.1002/ijc.23454
- By:
- Publication type:
- Article
24
A new model to predict risk of nonsentinel lymph node status in Chinese sentinel lymph node‐positive patients after neoadjuvant chemotherapy.
- Published in:
- Breast Journal, 2018, v. 24, n. 6, p. 883, doi. 10.1111/tbj.13065
- By:
- Publication type:
- Article
25
Breast-Conserving Surgery with Immediate Partial Breast Reconstruction by Using Pedicled Thoracodorsal Artery Perforator Flap: A 7-Year Follow-Up of 50 Women.
- Published in:
- Breast Care, 2024, v. 19, n. 6, p. 297, doi. 10.1159/000541340
- By:
- Publication type:
- Article
26
Effect of Trastuzumab among HER2-Positive Breast Cancer Patients that Achieved Pathologic Complete Response after Neoadjuvant Chemotherapy.
- Published in:
- Breast Care, 2019, v. 14, n. 6, p. 388, doi. 10.1159/000495186
- By:
- Publication type:
- Article
27
Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
28
Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00284-y
- By:
- Publication type:
- Article
29
Feasibility of using negative ultrasonography results of axillary lymph nodes to predict sentinel lymph node metastasis in breast cancer patients.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 7, p. 3066, doi. 10.1002/cam4.1606
- By:
- Publication type:
- Article
30
Impact of the addition of carboplatin to anthracycline‐taxane‐based neoadjuvant chemotherapy on survival in BRCA1/2‐mutated triple‐negative breast cancer.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 4, p. 941, doi. 10.1002/ijc.33234
- By:
- Publication type:
- Article
31
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 12, p. 3335, doi. 10.1002/ijc.32918
- By:
- Publication type:
- Article
32
BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 11, p. 3044, doi. 10.1002/ijc.32877
- By:
- Publication type:
- Article
33
Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 2, p. 487, doi. 10.1002/ijc.32424
- By:
- Publication type:
- Article
34
Effect of Local Versus General Anesthesia in Breast-Conserving Surgery on Cancer Recurrence and Cost.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2022, v. 29, p. 1, doi. 10.1177/10732748221083078
- By:
- Publication type:
- Article
35
Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 3, p. 605, doi. 10.1007/s10549-019-05483-7
- By:
- Publication type:
- Article
36
Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 3, p. 749, doi. 10.1007/s10549-019-05199-8
- By:
- Publication type:
- Article
37
Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 3, p. 639, doi. 10.1007/s10549-018-05124-5
- By:
- Publication type:
- Article
38
Identification and analysis of <italic>CHEK2</italic> germline mutations in Chinese <italic>BRCA1/2</italic>-negative breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 169, n. 1, p. 59, doi. 10.1007/s10549-018-4673-6
- By:
- Publication type:
- Article
39
<sup>99m</sup>Tc-rituximab as a tracer for sentinel lymph node biopsy in breast cancer patients: a single-center analysis.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 2, p. 365, doi. 10.1007/s10549-017-4591-z
- By:
- Publication type:
- Article
40
Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 158, n. 3, p. 455, doi. 10.1007/s10549-016-3902-0
- By:
- Publication type:
- Article
41
A single-center, randomized, parallel controlled study comparing the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 157, n. 3, p. 527, doi. 10.1007/s10549-016-3843-7
- By:
- Publication type:
- Article
42
Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 156, n. 3, p. 441, doi. 10.1007/s10549-016-3766-3
- By:
- Publication type:
- Article
43
Efficacy of physical examination, ultrasound, and ultrasound combined with fine-needle aspiration for axilla staging of primary breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 3, p. 761, doi. 10.1007/s10549-015-3280-z
- By:
- Publication type:
- Article
44
Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 132, n. 2, p. 421, doi. 10.1007/s10549-011-1596-x
- By:
- Publication type:
- Article
45
Somatic mutations in the BRCA1 gene in Chinese women with sporadic breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- Report
46
RAD51C germline mutations in Chinese women with familial breast cancer.
- Published in:
- 2011
- By:
- Publication type:
- Letter
47
BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 117, n. 1, p. 55, doi. 10.1007/s10549-008-0066-6
- By:
- Publication type:
- Article
48
Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
- Published in:
- Breast Cancer Research & Treatment, 2006, v. 97, n. 1, p. 49, doi. 10.1007/s10549-005-9086-7
- By:
- Publication type:
- Article
49
Ultrasound as a replacement for physical examination in clinical staging of axillary lymph nodes in breast cancer patients.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 1, p. 48, doi. 10.1111/1759-7714.13224
- By:
- Publication type:
- Article
50
Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer.
- Published in:
- Familial Cancer, 2021, v. 20, n. 2, p. 85, doi. 10.1007/s10689-020-00202-4
- By:
- Publication type:
- Article